Gabapentin-induced hypersensitivity syndrome

被引:18
作者
Ragucci, MV [1 ]
Cohen, JM [1 ]
机构
[1] NYU, Sch Med,Med Ctr, Rusk Inst, Dept Rehabil Med, New York, NY 10016 USA
关键词
hypersensitivity syndrome; gabapentin; fever; rash;
D O I
10.1097/00002826-200103000-00007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hypersensitivity syndrome is a rare but potentially fatal reaction to some pharmacologic agents, including some antiepileptic drugs. Typically, the syndrome presents with fever, rash, tender lymphadenopathy, hepatitis, and eosinophilia. We report a novel case of clinical hypersensitivity syndrome secondary to gabapentin. A patient developed altered mental status, fever, diffuse macular rash, and an enlarged spleen. This constellation of symptoms and signs began 9 days after gabapentin therapy was begun. Quick resolution was noted after gabapentin was discontinued. To our knowledge, there are no reports of hypersensitivity syndrome to gabapentin.
引用
收藏
页码:103 / 105
页数:3
相关论文
共 7 条
  • [1] DILANTIN SENSITIVITY - REPORT OF A CASE OF HEPATITIS WITH JAUNDICE, PYREXIA AND EXFOLIATIVE DERMATITIS
    CHAIKEN, BH
    GOLDBERG, BI
    SEGAL, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1950, 242 (23) : 897 - 898
  • [2] THE INCIDENCE OF ERYTHEMA MULTIFORME, STEVENS-JOHNSON SYNDROME, AND TOXIC EPIDERMAL NECROLYSIS - A POPULATION-BASED STUDY WITH PARTICULAR REFERENCE TO REACTIONS CAUSED BY DRUGS AMONG OUTPATIENTS
    CHAN, HL
    STERN, RS
    ARNDT, KA
    LANGLOIS, J
    JICK, SS
    JICK, H
    WALKER, AM
    [J]. ARCHIVES OF DERMATOLOGY, 1990, 126 (01) : 43 - 47
  • [3] Skin eruption with gabapentin in a patient with repeated AED-induced Stevens-Johnson's syndrome
    DeToledo, JC
    Minagar, A
    Lowe, MR
    Ramsay, RE
    [J]. THERAPEUTIC DRUG MONITORING, 1999, 21 (01) : 137 - 138
  • [4] Hamer HM, 1999, CLEV CLIN J MED, V66, P239
  • [5] MEDICATION USE AND THE RISK OF STEVENS-JOHNSON SYNDROME OR TOXIC EPIDERMAL NECROLYSIS
    ROUJEAU, JC
    KELLY, JP
    NALDI, L
    RZANY, B
    STERN, RS
    ANDERSON, T
    AUQUIER, A
    BASTUJIGARIN, S
    CORREIA, O
    LOCATI, F
    MOCKENHAUPT, M
    PAOLETTI, C
    SHAPIRO, S
    SHEAR, N
    SCHOPF, E
    KAUFMAN, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1600 - 1607
  • [6] Overview of the safety of newer antiepileptic drugs
    Shorvon, S
    Stefan, H
    [J]. EPILEPSIA, 1997, 38 : S45 - S51
  • [7] Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study
    Tennis, P
    Stern, RS
    [J]. NEUROLOGY, 1997, 49 (02) : 542 - 546